pembrolizumab,Lenvatinib,Doxorubicin
Merck,Teva Pharmaceuticals,sopherion,eisai
['pembro', 'gyn', 'lenva']
continued benefit was seen with lenvatinib and pembrolizumab in patients with advanced endometrial cancer who previously received platinum chemotherapy. #gyncsm #esmo2022 | 
Oncology news and insights from leading researchers and cancer centers.